Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00275288 · ClinicalTrials.gov registry record

MRI Imaging in Borderline Personality Disorder

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
20
Enrollment target

NCT00275288: Completed study, sponsored by University of Minnesota.

NCT00275288 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00275288 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

MRI Study for females ages 18-45 with Borderline Personality Disorder(BPD): This study is a non-treatment study that involves 2 visits. Study Hypothesis: 1. To refine and pilot test functional neuroimaging paradigms to assess the amygdala response to neutral facial expressions across positive and negative emotional contexts. 2. To assess whether patients with borderline personality disorder show a heightened amygdala response to neutral facial expressions relative to healthy controls (20 female healthy controls, 20 females with borderline personality disorder). 3. To assess the relationship between individual differences in clinical ratings of personality and affective regulation, and the amygdala response to facial expressions.

Primary Outcome

1. To refine and pilot test functional neuroimaging paradigms to assess the amygdala response to neutral facial expressions across positive and negative emotional contexts. 2. To assess whether patients with borderline personality disorder show a heightened amygdala response to neutral facial expressions relative to healthy controls (20 female healthy controls, 20 females with borderline personality disorder). 3. To assess the relationship between individual differences in clinical ratings of pe

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2005-01
Est. Completion 2007-06
University of Minnesota

966 total trials

What the finished NCT00275288 record still lists

NCT00275288 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00275288 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00275288 about?

NCT00275288 is a clinical study titled "MRI Imaging in Borderline Personality Disorder". MRI Study for females ages 18-45 with Borderline Personality Disorder(BPD): This study is a non-treatment study that involves 2 visits. Study Hypothesis: 1. To refine and pilot test functional neuroimaging paradigms to assess the amygdala response to neutral facial expressions across positive and n...

What is the current status of trial NCT00275288?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-01. Estimated completion is 2007-06.

Who is sponsoring clinical trial NCT00275288?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00275288, the US trial registry maintained by the National Library of Medicine. NCT00275288 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.